Khora analyzes clinical trials, regulatory data, and scientific evidence to evaluate credibility and help investors assess risk with confidence.
90%
of drug candidates fail before approval
4-24
weeks of diligence based on company complexity
$2.6B
average cost per approved drug
Clinical Trial Analysis
Evaluate trial credibility in minutes
Khora automatically assesses methodology, statistical validity, and endpoint design across thousands of clinical trials — surfacing the signals that matter most.
"At GlycoX, we're excited about Khora's potential to provide independent, standardized validation of what truly constitutes strong, meaningful data."
Co-founder and CEO, GlycoX
Matias Gonzalez
Khora does it better.
Khora
Integrates clinical registries, FDA filings, and literature into one analysis layer.
Delivers credibility assessments in minutes for real-time diligence.
Monitors updates continuously and alerts when evidence changes.
Other solutions
Depend on manually curated reports and limited public datasets.
Require weeks of expert review for initial recommendations.
Miss key developments between periodic update cycles.
Turning complex clinical data into investment clarity.
Khora analyzes clinical trials, regulatory data, and scientific evidence to evaluate the credibility of biotech innovation, helping investors assess risk and identify opportunities with confidence.
90%
4-24
$2.6B
of drug candidates fail before approval
weeks of diligence based on complexity
of biotech / life sciences company
average cost per approved drug
Clinical Trial Analysis
Evaluate trial credibility in minutes
Khora automatically assesses methodology, statistical validity, and endpoint design across thousands of clinical trials — surfacing the signals that matter most.
"At GlycoX, we're excited about Khora's potential to provide independent, standardized validation of what truly constitutes strong, meaningful data. Beyond helping VCs allocate capital more effectively, this kind of platform can accelerate the path from discovery to real solutions that improve patients' lives."
Co-founder and CEO, GlycoX
Matias Gonzalez
Khora does it better.
Data Sources
Analysis Speed
Scoring Methodology
Continuous Monitoring
Khora
Integrates clinical trial registries, FDA filings, PubMed, and proprietary datasets into a unified analysis.
Delivers comprehensive credibility assessments in minutes, enabling real-time due diligence.
Automated alerts on trial updates, regulatory changes, and new evidence that impacts credibility scores.
Other Solutions
Relies on manually curated reports and limited public data, requiring significant analyst time.
Weeks of manual review by specialized analysts before investment recommendations are finalized.
Subjective expert opinions with inconsistent frameworks across different analysts and firms.
Periodic manual updates that often miss critical developments between review cycles.
Join the Waitlist
Get early access to our beta, and Khora product updates
Evidence-based credibility scoring
Our proprietary algorithm evaluates trial methodology, statistical validity, endpoint rigor, and regulatory alignment to generate a comprehensive credibility score for any biotech claim.
Real-time regulatory monitoring
Track FDA submissions, EMA filings, and global regulatory developments as they happen.
Get instant alerts when new data impacts your portfolio companies.
Portfolio risk assessment
Continuously monitor the clinical evidence landscape for all companies in your portfolio. Identify emerging risks before they impact valuations.
Clinical Credibility Score
Focus on data that drives impact
Track, analyze, and improve your investment decisions—focus on credibility, measure risk with real-time data, and uncover opportunities for better returns.
87%
Trial Design Score
Based on 24 parameters
↑ 12% from Phase I
92%
Statistical Validity
Across 3 endpoints
↑ 8% vs. industry avg
The leading intelligence platform for biotech evaluation
Khora Venture Capital
Quantifying scientific risk to drive smarter biotech investment decisions.
Khora Markets
Translating clinical evidence into real-time signals for biotech markets.
Khora Portfolio
A unified intelligence layer for tracking and benchmarking biotech assets.
Khora Reports
Institutional-grade analysis turning complex science into actionable insight.
Khora Clinical
Standardizing trial quality to accelerate better clinical outcomes.
Khora Founder
Equipping biotech founders with the data to build and fund credible science.
Khora Regulatory
De-risking regulatory pathways through structured evidence intelligence.
